Funding Clinical Trials

Funding Clinical Trials

Our Agency funds clinical trials testing promising stem cell-based treatments for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.

CIRM Clinical Dashboard

Disease Areas Investigatorsort descending Organization Phase Trial Status Targeted Enrollment Detail
Mehrdad Abedi University of California, Davis Phase 1/2 Recruiting 18
Krystof Bankiewicz Brain Neurotherapy Bio Phase 1 Recruiting 12
Paolo Baroldi Medeor Therapeutics, Inc. Phase 3 Recruiting 30
Francois Binette Lineage Cell Therapeutics Inc. Phase 1/2 Completed 25
Christine Brown City of Hope, Beckman Research Institute Phase 1 Recruiting 92
Pierre Caudrelier ExCellThera Inc. Phase 1 Launching N/A
Mark Chao Forty Seven Inc. Phase 1/2 Completed 78
  • Leukemia, Acute Myeloid (AML)
Mark Chao Forty Seven Inc. Phase 1 Recruiting 96
Stephanie Cherqui University of California, San Diego Phase 1/2 Recruiting 6
  • Beta Thalassemia
Bettina Cockroft Sangamo BioSciences, Inc. Phase 1/2 Active, not recruiting 6
  • Severe Combined Immunodeficiency, Artemis deficient (ART-SCID)
Morton Cowan University of California, San Francisco Phase 1 Recruiting 15
  • Leukemia, Acute Myeloid (AML)
Colleen Delaney Nohla Therapeutics Inc Phase 2 Terminated 146
  • Corneal Damage
Sophie Deng University of California, Los Angeles Phase 1 Recruiting 20
Robert Dillman Caladrius Biosciences Phase 3 Terminated 4
Steven Dubinett University of California, Los Angeles Phase 1 Recruiting 36
Paul Finnegan Angiocrine Bioscience, Inc. Phase 1 Recruiting 9
Howard Foyt ViaCyte, Inc. Phase 1/2 Active, not recruiting 69
Howard Foyt ViaCyte, Inc. Phase 1/2 Recruiting 75
Stephen Gottschalk St. Jude Children's Research Hospital Phase 1/2 Recruiting 28
Anthony Gringeri ImmunoCellular Therapeutics Phase 3 Suspended 414
Mark Humayun University of Southern California Phase 1 Active, not recruiting 16
Kristen Johnson Calibr Phase 1 Completed 60
Edward Kavalerchik Angiocrine Bioscience, Inc. Phase 1 Recruiting 24
Ralph Kern BrainStorm Cell Therapeutics Phase 3 Active, not recruiting 261
Thomas Kipps University of California, San Diego Phase 1 Completed 26
Thomas Kipps University of California, San Diego Phase 1/2 Recruiting 156
Henry Klassen University of California, Irvine Phase 1/2 Completed 28
Henry Klassen jCyte, Inc Phase 2 Active, not recruiting 84
Henry Klassen jCyte, Inc Phase 2 Active, not recruiting 84
  • X-linked Chronic Granulomatous Disease
Donald Kohn University of California, Los Angeles Phase 1/2 Active, not recruiting 10
Donald Kohn University of California, Los Angeles Phase 1 Recruiting 6
Donald Kohn University of California, Los Angeles Phase 2 Completed 10
Nancy Lane University of California, Davis Phase 1/2 Active, not recruiting 50
Jeffrey Lawson Humacyte, Inc. Phase 3 Active, not recruiting 355
Jeffrey Lawson Humacyte, Inc. Phase 3 Recruiting 240
Jane Lebkowski Geron Corporation Phase 1 Completed 5
  • Pulmonary Hypertension
Michael Lewis Cedars-Sinai Medical Center Phase 1/2 Recruiting 26
Douglas Losordo Caladrius Biosciences Phase 2 Active, not recruiting 113
Crystal Mackall Stanford University Phase 1 Recruiting 57
  • Alpha Thalassemia Major
Tippi MacKenzie University of California, San Francisco Phase 1 Recruiting 10
Linda Marban Capricor, Inc Phase 2 Completed 25
  • COVID-19
Michael Matthay University of California, San Francisco Phase 2 Recruiting 120
Everett Meyer Stanford University Phase 1 Recruiting 22
Bijan Nejadnik SanBio, Inc. Phase 2 Completed 302
  • Sarcoma
Theodore Nowicki University of California, Los Angeles Phase 1 Recruiting 12
  • Leukocyte Adhesion Deficiency
Kinnari Patel Rocket Pharmaceuticals, Inc. Phase 1/2 Recruiting 9
Saul Priceman City of Hope, Beckman Research Institute Phase 1 Recruiting 39
Michael Pulsipher Children's Hospital of Los Angeles Phase 1/2 Recruiting 60
Antoni Ribas University of California, Los Angeles Phase 1 Recruiting 12
Joseph Rosenthal City of Hope, Beckman Research Institute Phase 1 Recruiting 6
Judith Shizuru Stanford University Phase 1/2 Recruiting 90
Dennis Slamon University of California, Los Angeles Phase 1 Recruiting 48
Rachel Smith Capricor, Inc Phase 2 Terminated 156
  • Multiple Myeloma
Matthew Spear Poseida Therapeutics, Inc. Phase 1 Recruiting 220
Peter Stock University of California, San Francisco Phase 1/2 Recruiting 8
Samuel Strober Stanford University Phase 1 Active, not recruiting 15
Clive Svendsen Cedars-Sinai Medical Center Phase 1/2 Active, not recruiting 18
Clive Svendsen Cedars-Sinai Medical Center Phase 1 Recruiting 16
Geoff Symonds Calimmune, Inc. Phase 1/2 Completed 12
Irving Weissman Stanford University Phase 1 Completed 88
Vicki Wheelock University of California, Davis Phase 1/2 Completed 29
John Zaia City of Hope, Beckman Research Institute Phase 1 Active, not recruiting 12
  • COVID-19
John Zaia City of Hope, Beckman Research Institute Phase 1 Launching N/A
Icon for XLSX export